Showing 1 - 10 of 61
Persistent link: https://www.econbiz.de/10015306220
Persistent link: https://www.econbiz.de/10009638927
member GHK with support from EPEC partner Technopolis. The work has been undertaken under the guidance of a Reference Group …
Persistent link: https://www.econbiz.de/10011476705
The study assesses the overall functioning and performance of the Product Liability Directive and whether it is effective, efficient, coherent and relevant and has EU added value. Attention is paid to analysing whether the Product Liability Directive is fit for purpose, as regards new...
Persistent link: https://www.econbiz.de/10015285199
Europe's population is ageing as a result of falling birth rates and higher life expectancy, which will bring a number of challenges but also represents an important economic opportunity for Europe's businesses. Older citizens are increasingly shaping economies, constituting a large and growing...
Persistent link: https://www.econbiz.de/10015285255
Persistent link: https://www.econbiz.de/10015285291
-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW), and undertaken by a consortium led by Technopolis …
Persistent link: https://www.econbiz.de/10015285583
This evaluation concerns the implementation of Regulation (EU) No 386/2012 on entrusting the European Union Intellectual Property Office (EUIPO) (former OHIM) with tasks related to the enforcement of intellectual property rights (IPRs), including assembling public- and private-sector...
Persistent link: https://www.econbiz.de/10015285706
This evaluation concerns the implementation of Regulation (EU) No 386/2012 on entrusting the European Union Intellectual Property Office (EUIPO) (former OHIM) with tasks related to the enforcement of intellectual property rights (IPRs), including assembling public- and private-sector...
Persistent link: https://www.econbiz.de/10015285709
The current study is aimed at providing a review of the economic impacts of the Regulation since it entered into force until the end of 2015. This study thus covers the following dimensions: (i) Analysis of the regulatory costs to the pharmaceutical industry for meeting legal obligations; (ii)...
Persistent link: https://www.econbiz.de/10015285792